Exercise during curative chemotherapy for breast cancer has proven benefits. It helps reduce fatigue, preserve muscle strength, improve fitness, and enhance overall quality of life. Staying physically active…
With a wave of FDA approvals and promising clinical trials, treatment options for metastatic breast cancer are expanding fast. Amy Tiersten, MD, highlights the power of immunotherapies—especially checkpoint…
NEW YORK (Reuters Health) – It’s possible that more than 1 million men in the US have been needlessly treated for prostate cancer since the late 1980s, when…
NEW YORK (Reuters Health) – Nadroparin, a low-molecular-weight heparin, reduces the incidence of thromboembolic events in ambulatory patients receiving chemotherapy for metastatic or locally advanced solid cancers, an…
NEW YORK (Reuters Health) – Hormone replacement therapy (HRT) with estrogen/progestin reduces the risk of colorectal cancer, but Israeli researchers have found that aspirin use and an active…
NEW YORK (Reuters Health) – “There is no strong evidence” that any significant subpopulation of breast cancer patients diagnosed in the 1980s and early 1990s was ever “cured,”…
NEW YORK (Reuters Health) – Patients with high-risk esophageal varices treated with the beta-blocker carvedilol had lower rates of first bleeding episodes than patients treated with variceal band…
The diagnosis of prostate cancer can be a confusing and scary time for many men. Ken Burger discusses his process of learning to adapt and deal with the…
NEW YORK (Reuters Health) – Laparoscopic surgery is as efficient as open surgery for rectal cancer, according to results of a randomized trial. Dr. Juan Lujan and colleagues…
NEW YORK (Reuters Health) – The median survival of patients with peritoneal breast cancer metastasis is “surprisingly poor,” with only a small minority surviving longer than 6 months,…
NEW YORK (Reuters Health) – Because of their ability to prevent, reduce, and delay skeletal complications with multiple myeloma, bisphosphonates are an essential component of treatment for this…
NEW YORK (Reuters Health) – Women treated for grade 1 breast cancer have a low risk of locoregional recurrence and contralateral breast cancer, results of a study indicate.…
